UNSPSC 51343814: Efavirenz/lamivudine/tenofovir DF

This classification denotes a combination drug for treatment of HIV. The first component, EFAVIRENZ, has US FDA Unique Ingredient Identifier of JE6H2O27P8. The second component, LAMIVUDINE, has US FDA Unique Ingredient Identifier of 2T8Q726O95. The third component, TENOFOVIR DISOPROXIL FUMARATE, has US FDA Unique Ingredient Identifier of OTT9J7900I.

UNSPSC 51343814 Efavirenz/lamivudine/tenofovir DF is a Commodity code tracking antiretroviral pharmaceutical products. The code shows minimal recent activity tied directly to the product itself; the most recent state and local opportunities tagged under this code diverge significantly from its nominal scope. Of the opportunities in the dataset, only one—Dane County's RFP for pharmaceutical services to Badger Prairie Health Care Center (due October 22, 2026)—involves pharmaceutical procurement and dispensing operations at a state or local facility, though the solicitation addresses broad pharmaceutical services rather than this specific antiretroviral formulation. Most other records in the dataset concern naloxone distribution, forensic drug standards, EMS medication vending and software platforms, and non-competitive events, none of which align with procurement of the named product.

Dane County's pharmaceutical-services RFP represents the clearest relevant activity: the county seeks a comprehensive pharmacy benefit provider for its long-term care facility, with pricing tied to Wholesale Average Cost or Average Wholesale Price methodologies, local-vendor preference points, a five-year initial term, and estimated annual spend of $125,000. Beyond that single solicitation, the code shows no traceable recent demand from state or local procurement bodies specifically for efavirenz/lamivudine/tenofovir combinations or similar fixed-dose antiretroviral therapies. The dataset includes one notice from the District of Columbia regarding pharmacy-benefits-program participation (due October 7, 2026), but it provides no scope detail. Geographic activity is limited to Wisconsin and the District of Columbia. No pre-bid meetings, industry days, or vendor outreach events specific to this product or code tier appear in recent state and local procurement channels; the only events posted were general procurement conferences in Florida and Oregon unrelated to pharmaceuticals. Pursuit of this code requires validation that state and local procurement bodies are actively acquiring this specific formulation—current public records do not demonstrate material recent volume or frequency.